Skip to main content

Schuler Jack W's Form 4 filing

Soleno Therapeutics Inc (SLNO) · filed May 15, 2023

Accession no.
0001175707-23-000146
Filed
May 15, 2023
Trade date
Oct 13-Dec 8, 2022
Filing delay
214 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 30 non-derivative transactions. Open-market sales total $465.3K. It was filed 214 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schuler Jack WCIK 000102141210% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 13, 2022Common StockSSaleDisposed−400$1.52−$608466,266Indirect
Oct 26, 2022Common StockSSaleDisposed−8,842$1.26−$11,140.92457,424Indirect
Oct 27, 2022Common StockSSaleDisposed−9,100$1.16−$10,556448,324Indirect
Oct 28, 2022Common StockSSaleDisposed−10,000$1.08−$10,800438,324Indirect
Oct 31, 2022Common StockSSaleDisposed−10,000$1.00−$10,000428,324Indirect
Nov 1, 2022Common StockSSaleDisposed−10,000$0.99−$9,900418,324Indirect
Nov 2, 2022Common StockSSaleDisposed−10,000$0.97−$9,700408,324Indirect
Nov 3, 2022Common StockSSaleDisposed−10,000$1.01−$10,100398,324Indirect
Nov 4, 2022Common StockSSaleDisposed−10,000$0.99−$9,900388,324Indirect
Nov 7, 2022Common StockSSaleDisposed−10,000$0.99−$9,900378,324Indirect
Nov 8, 2022Common StockSSaleDisposed−10,000$0.99−$9,900368,324Indirect
Nov 9, 2022Common StockSSaleDisposed−10,000$0.94−$9,400358,324Indirect
Nov 14, 2022Common StockSSaleDisposed−10,000$1.07−$10,700348,324Indirect
Nov 15, 2022Common StockSSaleDisposed−10,000$1.09−$10,900338,324Indirect
Nov 16, 2022Common StockSSaleDisposed−116,882$1.26−$147,271.32221,442Indirect
Nov 17, 2022Common StockSSaleDisposed−11,442$1.15−$13,158.3210,000Indirect
Nov 18, 2022Common StockSSaleDisposed−28,474$1.15−$32,745.1181,526Indirect
Nov 21, 2022Common StockSSaleDisposed−14,531$1.13−$16,420.03166,995Indirect
Nov 22, 2022Common StockSSaleDisposed−10,000$1.07−$10,700156,995Indirect
Nov 23, 2022Common StockSSaleDisposed−10,400$1.11−$11,544146,595Indirect
Nov 25, 2022Common StockSSaleDisposed−10,000$1.07−$10,700136,595Indirect
Nov 28, 2022Common StockSSaleDisposed−10,000$1.05−$10,500126,595Indirect
Nov 29, 2022Common StockSSaleDisposed−10,000$1.01−$10,100116,595Indirect
Nov 30, 2022Common StockSSaleDisposed−10,000$0.99−$9,900106,595Indirect
Dec 1, 2022Common StockSSaleDisposed−10,000$1.03−$10,30096,595Indirect
Dec 2, 2022Common StockSSaleDisposed−10,000$1.00−$10,00086,595Indirect
Dec 5, 2022Common StockSSaleDisposed−10,000$0.97−$9,70076,595Indirect
Dec 6, 2022Common StockSSaleDisposed−10,000$0.99−$9,90066,595Indirect
Dec 7, 2022Common StockSSaleDisposed−10,000$0.96−$9,60056,595Indirect
Dec 8, 2022Common StockSSaleDisposed−10,000$0.93−$9,30046,595Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)